PT1448186E - Medicamento para o tratamento de doenças virais da pele e doenças tumorais - Google Patents

Medicamento para o tratamento de doenças virais da pele e doenças tumorais Download PDF

Info

Publication number
PT1448186E
PT1448186E PT02803380T PT02803380T PT1448186E PT 1448186 E PT1448186 E PT 1448186E PT 02803380 T PT02803380 T PT 02803380T PT 02803380 T PT02803380 T PT 02803380T PT 1448186 E PT1448186 E PT 1448186E
Authority
PT
Portugal
Prior art keywords
patients
cure
alkenyl
alkyl
active agent
Prior art date
Application number
PT02803380T
Other languages
English (en)
Inventor
Yunik Chang
Ro Lathrop
Erwin Boehm
Irene Gander-Meisterernst
Regina Greger
Johanna Holldack
Ulrich Moebius
Original Assignee
Medigene Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26010614&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1448186(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10156794A external-priority patent/DE10156794B4/de
Application filed by Medigene Ag filed Critical Medigene Ag
Publication of PT1448186E publication Critical patent/PT1448186E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PT02803380T 2001-11-19 2002-11-18 Medicamento para o tratamento de doenças virais da pele e doenças tumorais PT1448186E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33170501P 2001-11-19 2001-11-19
DE10156794A DE10156794B4 (de) 2001-11-19 2001-11-19 Arzneimittel zur Behandlung von Warzen

Publications (1)

Publication Number Publication Date
PT1448186E true PT1448186E (pt) 2009-03-24

Family

ID=26010614

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02803380T PT1448186E (pt) 2001-11-19 2002-11-18 Medicamento para o tratamento de doenças virais da pele e doenças tumorais

Country Status (19)

Country Link
US (4) US7858662B2 (pt)
EP (2) EP1448186B1 (pt)
JP (1) JP4495459B2 (pt)
KR (1) KR100956369B1 (pt)
CN (1) CN1323660C (pt)
AT (1) ATE417611T1 (pt)
BR (1) BRPI0214256B8 (pt)
CA (1) CA2466720C (pt)
CY (1) CY1108882T1 (pt)
DE (2) DE50213137D1 (pt)
DK (1) DK1448186T3 (pt)
ES (1) ES2319626T3 (pt)
HK (2) HK1073788A1 (pt)
IL (2) IL161625A0 (pt)
MX (1) MXPA04004532A (pt)
PT (1) PT1448186E (pt)
RU (1) RU2302861C3 (pt)
WO (1) WO2003043628A1 (pt)
ZA (1) ZA200403287B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2319626T3 (es) 2001-11-19 2009-05-11 Medigene Ag Farmaco para el tratamiento de enfermedades tumorales y de la piel virales.
ITMI20030210A1 (it) * 2003-02-07 2004-08-08 Res & Innovation Soc Coop A R L Composti endocannabinoido-simili e loro impiego
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US20050079235A1 (en) * 2003-10-09 2005-04-14 Eggert Stockfleth Use of a polyphenol for the treatment of actinic keratosis
NZ546323A (en) * 2003-10-09 2009-04-30 Medigene Ag The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
KR100665315B1 (ko) 2004-03-25 2007-01-09 한국원자력연구소 신규한 갈릭산-콘쥬게이티드 리놀레산 지방 에스테르, 이의 제조방법 및 이를 함유하는 조성물
CA2599667C (en) 2005-03-10 2014-12-16 3M Innovative Properties Company Antimicrobial compositions comprising esters of hydroxy carboxylic acids
EP1858506A2 (en) 2005-03-10 2007-11-28 3M Innovative Properties Company Methods of treating ear infections
CA2599653A1 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
EP2179722A1 (en) * 2008-10-24 2010-04-28 Heinrich-Pette-Institut für experimentelle Virologie und Immunologie Topical formation for preventing sexual transmission of viral infection
CN102949387B (zh) * 2011-08-19 2017-03-01 奥古斯塔大学研究所公司 用于治疗单纯疱疹病毒的组合物和方法
JP5796006B2 (ja) * 2011-12-14 2015-10-21 有限会社 ワーコム農業研究所 抗菌剤
RU2600033C2 (ru) * 2014-10-16 2016-10-20 Юрий Николаевич Родионов Способ получения вещества для разрушения микроциркуляторного русла удаляемого кожного образования
US9750716B2 (en) 2015-03-19 2017-09-05 Wendy Anne Epstein Compounds and forms of treatment for female sexual disorders
CN107349197A (zh) * 2017-07-13 2017-11-17 黄冈师范学院 一种儿茶素在制备治疗皮肤乳头状瘤的药物上的应用
KR20230149132A (ko) 2022-04-19 2023-10-26 고려대학교 산학협력단 카테콜 화합물 또는 이의 유도체 화합물을 유효성분으로 포함하는 엡스타인-바 바이러스에 대한 항바이러스용 조성물

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002775A (en) * 1973-07-09 1977-01-11 Kabara Jon J Fatty acids and derivatives of antimicrobial agents
JPS55105677A (en) * 1979-02-07 1980-08-13 Norin Suisansyo Chiyagiyou Shikenjo Production of catechins
EP0087161A3 (en) * 1982-02-24 1984-04-04 Key Pharmaceuticals, Inc. Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
JPS59219384A (ja) * 1983-05-30 1984-12-10 Mitsui Norin Kk 天然抗酸化剤の製造方法
JPS6013780A (ja) * 1983-07-05 1985-01-24 Mitsui Norin Kk 茶カテキン類の製造方法
JPS61238728A (ja) * 1985-04-16 1986-10-24 Mitsui Norin Kk 茶葉抽出物と活性水酸化アルミニウムとの抗潰瘍性複合体
SE462894B (sv) * 1985-10-28 1990-09-17 Biogram Ab Mikrokapslar, foerfarande foer framstaellning daerav samt anvaendning
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US5204089A (en) * 1989-08-30 1993-04-20 Mitsui Norin Co., Ltd. Method of preventing the formation or aggrevation of dental plaque and method for reducing cariogenesis
JP2727471B2 (ja) * 1989-09-14 1998-03-11 三井農林株式会社 インフルエンザウィルス感染予防剤
JP2888554B2 (ja) * 1989-09-20 1999-05-10 三井農林株式会社 マイコプラズマ感染予防剤
US5318986A (en) * 1989-10-19 1994-06-07 Mitsui Norin Co., Ltd. Method of inhibiting the activity of α-amylase
US5358713A (en) * 1990-02-23 1994-10-25 Mitsui Norin Co., Ltd. Method of preventing the transmission of infection caused by methicillin-resistant Staphylococcus aureus
JP3019996B2 (ja) * 1990-03-01 2000-03-15 三井農林株式会社 白癬治療剤
JPH04253918A (ja) 1991-02-05 1992-09-09 Mitsui Norin Kk 血糖上昇抑制剤
DK0644766T3 (da) * 1992-06-08 1999-10-11 Pitmy Int Nv Dinitrogenoxid-holdigt dermatologisk præparat
US5306486A (en) * 1993-03-01 1994-04-26 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic sunscreen composition containing green tea and a sunscreen
JP3333584B2 (ja) * 1993-04-19 2002-10-15 三井農林株式会社 歯質の耐酸性強化組成物
JPH07196466A (ja) * 1993-12-29 1995-08-01 Sunstar Inc 茶の粉末を配合した化粧料組成物
US5670154A (en) * 1994-01-10 1997-09-23 Mitsui Norin Co., Ltd. Reducing tyrosinase activity
FR2718022B1 (fr) * 1994-04-01 1996-04-26 Roussel Uclaf Compositions cosmétiques ou dermatologiques et leur préparation.
IL115156A (en) * 1994-09-06 2000-07-16 Univ Georgia Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines
JP2718653B2 (ja) * 1995-01-31 1998-02-25 日本配合飼料株式会社 新規卵および卵質改良方法
IT1275905B1 (it) * 1995-03-14 1997-10-24 Indena Spa Frazioni polifenoliche di te', loro uso e formulazioni che le contengono
GB2300578B (en) * 1995-05-11 1998-01-14 Matsushita Seiko Kk Gargling cup,antiviral mask,antiviral filter,antifungal,antibacterial,and antiviral filter air cleaner and air-cleaner-humidifier
US5888527A (en) * 1995-05-11 1999-03-30 Matsushita Seiko Co., Ltd. Gargling cup, antiviral mask, antiviral filter, antifungal, antibacterial, and antiviral filter air cleaner and air-cleaner humidifier
JPH09132532A (ja) * 1995-09-06 1997-05-20 Mitsui Norin Kk 抗生物質の抗菌力増強方法
US6197806B1 (en) * 1995-12-20 2001-03-06 Nippon Zoki Pharmaceutical Co., Ltd. Eliminating agent for activated oxygen and free radicals
US6127393A (en) * 1995-12-29 2000-10-03 Novactyl, Inc. Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method
US5804567A (en) * 1996-07-18 1998-09-08 Cancer Institute (Hospital), Chinese Academy Of Medical Sciences Method of increasing the effectiveness of anti-metabolites
US6337320B1 (en) 1996-10-11 2002-01-08 Thione International, Inc. Reparatives for ultraviolet radiation skin damage
WO1998020872A1 (en) * 1996-11-14 1998-05-22 Halldor Thormar Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections
US6197808B1 (en) 1996-11-18 2001-03-06 Cancer Instititute (Hospital), Chinese Academy Of Medical Sciences Methods for treating hyperplasia
JP3213557B2 (ja) * 1996-11-18 2001-10-02 三井農林株式会社 茶カテキンを有効成分として含有する尖圭コンジローマ治療剤
US5968973A (en) * 1996-11-18 1999-10-19 Cancer Institute (Hospital), Chinese Academy Of Medical Sciences Method for treating hyperplasia
AU6436998A (en) * 1997-02-20 1998-09-09 Yale University Therapeutic uses for antioxidants
JP3202938B2 (ja) * 1997-03-18 2001-08-27 三井農林株式会社 チューインガム及びその製造法
US5910308A (en) * 1997-03-19 1999-06-08 Sante International Inc. Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis
US6372234B1 (en) 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
KR100269520B1 (ko) * 1997-07-29 2000-10-16 구본준 박막트랜지스터, 액정표시장치와 그 제조방법
US6696484B2 (en) * 1997-10-31 2004-02-24 University Of Chicago Office Of Technology And Intellectual Property Method and compositions for regulation of 5-alpha reductase activity
JP4738592B2 (ja) * 1997-10-31 2011-08-03 アーチ・デヴェロップメント・コーポレイション ５α−還元酵素活性を調節するための方法及び組成物
KR100417703B1 (ko) 1998-04-21 2004-02-11 미쓰이 노린 가부시키가이샤 항클라미디아제
US20020006447A1 (en) * 1998-04-21 2002-01-17 Mitsui Norin Co., Ltd. Anti-chlamydia agent
DE19827624A1 (de) * 1998-06-20 1999-12-23 Beiersdorf Ag Verwendung von einem mit einem Gehalt an Catecinen oder einem Gehalt an Extrakt von grünem Tee in kosmetischen Zubereitungen zur Bräunung der Haut
SE9803929D0 (sv) * 1998-11-18 1998-11-18 Medivir Ab Antiviral formulation
KR100319973B1 (ko) * 1998-12-05 2002-04-22 이인수 녹차카테킨을 유효성분으로 하는 자궁경부 상피내종양 예방 또는 치료제 조성물
US6210679B1 (en) * 1999-01-07 2001-04-03 Hauser, Inc. Method for isolation of caffeine-free catechins from green tea
DE19958159A1 (de) * 1999-12-02 2001-06-07 Degussa Neue für das glk-Gen codierende Nukleotidsequenzen
DE19962369A1 (de) * 1999-12-23 2001-06-28 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Catechinen oder einem Gehalt an Extrakt von grünem Tee und einem weiteren Gehalt an Ascorbinsäure
US6248341B1 (en) 2000-01-14 2001-06-19 Color Access, Inc. Method of treating topical angiogenesis-related disorders
US20020031535A1 (en) * 2000-09-11 2002-03-14 Sheffield Felix H. Topical formulation to treat skin disorders
US6713506B2 (en) * 2000-10-11 2004-03-30 University Of South Florida Tea polyphenol esters and analogs thereof for cancer prevention and treatment
ES2319626T3 (es) 2001-11-19 2009-05-11 Medigene Ag Farmaco para el tratamiento de enfermedades tumorales y de la piel virales.
US20030143165A1 (en) * 2002-01-25 2003-07-31 Allan Evans NSAID-containing topical formulations that demonstrate chemopreventive activity
US20030166583A1 (en) * 2002-02-22 2003-09-04 Oliver Yoa-Pu Hu Dermal cytochrome P450 1A inhibitors and enhancers
US6723750B2 (en) * 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
BRPI0204130B8 (pt) 2002-09-18 2021-05-25 Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp composição gel à base de extrato de pothomorphe umbellata, seus usos e método cosmético não-terapêutico.
US20040191842A1 (en) * 2002-12-10 2004-09-30 Medical College Of Georgia Research Institute, Inc. Chemopreventive and therapeutic aspects of polyphenolic compositions and assays
CA2518082C (en) * 2003-03-13 2013-02-12 3M Innovative Properties Company Methods for diagnosing skin lesions
US20050079235A1 (en) * 2003-10-09 2005-04-14 Eggert Stockfleth Use of a polyphenol for the treatment of actinic keratosis
NZ546323A (en) * 2003-10-09 2009-04-30 Medigene Ag The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin

Also Published As

Publication number Publication date
US7858662B2 (en) 2010-12-28
RU2302861C2 (ru) 2007-07-20
IL161625A (en) 2010-05-31
AU2002356673A1 (en) 2003-06-10
MXPA04004532A (es) 2004-08-11
DE50213137D1 (de) 2009-01-29
US20050032895A1 (en) 2005-02-10
RU2302861C3 (ru) 2017-04-14
HK1131048A1 (zh) 2010-03-12
ES2319626T3 (es) 2009-05-11
DK1448186T3 (da) 2009-04-14
US9770406B2 (en) 2017-09-26
CY1108882T1 (el) 2014-07-02
US20110009481A1 (en) 2011-01-13
CA2466720A1 (en) 2003-05-30
CN1323660C (zh) 2007-07-04
JP4495459B2 (ja) 2010-07-07
CN1589141A (zh) 2005-03-02
ZA200403287B (en) 2005-07-27
KR100956369B1 (ko) 2010-05-10
HK1073788A1 (en) 2005-10-21
CA2466720C (en) 2010-02-09
BRPI0214256B8 (pt) 2021-05-25
US20200054552A1 (en) 2020-02-20
DE122009000073I1 (de) 2010-03-25
EP2055300A3 (de) 2010-05-12
RU2004118667A (ru) 2005-04-10
BRPI0214256B1 (pt) 2016-06-28
ATE417611T1 (de) 2009-01-15
US20180193254A1 (en) 2018-07-12
JP2005514358A (ja) 2005-05-19
EP2055300B1 (de) 2016-01-27
WO2003043628A1 (de) 2003-05-30
US10434059B2 (en) 2019-10-08
EP2055300A2 (de) 2009-05-06
EP1448186B1 (de) 2008-12-17
EP1448186A1 (de) 2004-08-25
BR0214256A (pt) 2004-09-21
KR20050044344A (ko) 2005-05-12
IL161625A0 (en) 2004-09-27

Similar Documents

Publication Publication Date Title
HK1073788A1 (en) Medicament for the treatment of viral skin and tumour diseases
Golub et al. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources
MXPA01013042A (es) Acidos aldonicos de oligosacarido y su uso topico.
UA74346C2 (uk) Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
CA2396186A1 (en) Agents for the treatment of skin disorders
ATE188119T1 (de) Heilmittel für wunden und hämorrhoiden
AU8436401A (en) Methods and pharmaceutical compositions for healing wounds
IT1256111B (it) Sali dell'acido traumatico ad attivita' cicatrizzante ed antibatterica
ES2087623T3 (es) Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.
PL330768A1 (en) Perpetration for use in therapy and prophylactics of dermatological diseases
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
GB9023701D0 (en) Medical treatment
US5532275A (en) Method of promoting wound healing and scar regression
EP0009636A3 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivative, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds in the treatment and prophylaxis of diseases and for promoting growth of certain animals, and their manufacture
EG17992A (en) Preparation of a medicament for arthritis and theumatism
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
DE60233578D1 (de) Phosphorenthaltende Verbindugnen mit antithrombitische Wirkung
ZA892101B (en) Salicylic acid containing pharmaceutical preparations for treating scaly skin diseases
FR2403079A1 (fr) Composition pour le traitement de cancers a base d'esters d'acide glycyrrhetinique
HUT54039A (en) Process for producing galenic compositions ensuring optimal biological accessibility of 2-hydroxy-5-methyllaurophenoneoxime active ingredient
MX9302859A (es) Alcoholes terapeuticos.
SE9903609D0 (sv) Novel compounds I
BG107546U (en) Balm for the restoration of skin impairments
YU9302A (sh) Mikofenolat mofetil u kombinaciji sa peg-ifn-alfa